Tobam Seagen Inc. Transaction History

Tobam

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$108.81 - $179.33 $3.37 Million - $5.55 Million	-30,960 Reduced 73.07%	11,413 $2.02 Million
Q1 2022 Apr 25, 2022	SELL	$119.61 - $157.85 $12.2 Million - $16.1 Million	-101,693 Reduced 70.59%	42,373 $6.1 Million
Q4 2021 Feb 15, 2022	BUY	$142.57 - $190.86 $2.34 Million - $3.13 Million	16,390 Added 12.84%	144,066 $22.3 Million
Q3 2021 Nov 12, 2021	BUY	$142.45 - $169.82 $2.56 Million - $3.05 Million	17,983 Added 16.39%	127,676 $21.7 Million
Q2 2021 Aug 11, 2021	BUY	$135.08 - $161.1 $3.99 Million - $4.75 Million	29,514 Added 36.81%	109,693 $17.3 Million

Q1 2021 May 11, 2021	BUY	$137.51 - $190.8 $3.06 Million - $4.25 Million	22,259 Added 38.43%	80,179 $11.1 Million
Q4 2020 Feb 03, 2021	BUY	$164.63 - $211.93 $2.66 Million - $3.43 Million	16,170 Added 38.73%	57,920 $10.1 Million
Q3 2020 Nov 12, 2020	BUY	$145.95 - $195.69 $6.09 Million - $8.17 Million	41,750 New	41,750 $8.17 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

Stay updated on Tobam with notifications on news.